Skip to main content
Organon & Co. logo

Organon & Co. — Investor Relations & Filings

Ticker · OGN ISIN · US68622V1061 LEI · 549300AMCKY57OK2CO56 US Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2020-12-21 Regulatory Filings
Country US United States of America
Listing US OGN

About Organon & Co.

https://www.organon.com/

Organon & Co. is a global healthcare company dedicated to improving the health of women. The company's portfolio is structured around three core pillars: Women's Health, Biosimilars, and Established Brands. The Women's Health division focuses on reproductive health, including contraception and fertility, as well as other conditions unique to women. The Biosimilars business aims to provide more accessible treatment options, particularly in oncology and immunology. The Established Brands unit manages a diverse range of therapies for conditions such as cardiovascular disease, respiratory illnesses, dermatology, and neurology. Organon's portfolio includes more than 70 medicines and devices, which are available in over 140 markets.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 10 registration statement filed with the SEC pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It includes detailed information about the registrant, Organon & Co., and references an information statement filed as Exhibit 99.1. The document is a registration form for securities, not a financial report, earnings release, or management discussion. It is not an annual or interim report, nor a proxy or voting results announcement. The form is a regulatory filing related to securities registration and compliance with SEC rules. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (over 10,000 characters) and content confirm it is not a brief announcement or certification but a substantive regulatory filing.
2020-12-21 English
Regulatory Filings 2020
Regulatory Filings
2020-11-30 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a Form 10 registration statement filed with the SEC pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It includes cross-references to an information statement and various exhibits related to the registration of securities. The document is not an annual report, earnings release, or any other financial report but rather a registration statement for securities listing. This type of filing is a regulatory filing that does not fit into other specific categories such as 10-K, IR, or MDA. Therefore, it should be classified as a Regulatory Filing (RNS). The document length (8625 characters) and content confirm it is not merely an announcement but a substantive filing, yet it is not a financial report itself.
2020-11-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.